Antimalarial antisense activity of hexitol nucleic acids

Area of Science:

• Molecular Biology
• Parasitology
• Drug Discovery

Background:

• Current antimalarial drugs are failing against Plasmodium falciparum.
• Antisense oligonucleotides (ASOs) and ribozymes are promising tools for antimalarial drug development and gene identification.
• Improving the nuclease resistance of oligonucleotides is crucial for their therapeutic application.

Purpose of the Study:

• To assess the efficacy of antisense oligonucleotides with phosphorylated anhydrohexitol modifications in inhibiting Plasmodium falciparum growth.
• To compare the effectiveness of these modified ASOs with established phosphorothioated ASOs.

Main Methods:

• Culturing Plasmodium falciparum parasites.
• Synthesizing and applying antisense oligonucleotides with phosphorylated anhydrohexitol modifications.
• Evaluating parasite growth inhibition in a sequence-specific manner.
• Comparing results with phosphorothioated antisense oligonucleotides.

Main Results:

• The modified antisense oligonucleotides inhibited Plasmodium falciparum growth in a sequence-dependent manner.
• The inhibition achieved by the modified ASOs was less potent than that of phosphorothioated ASOs.
• Potential reasons for lower efficacy include the absence of RNase H activation and altered membrane transport.

Conclusions:

• Phosphorylated anhydrohexitol-modified antisense oligonucleotides demonstrate antimalarial activity but require further optimization.
• The observed differences in efficacy highlight the importance of RNase H activation and cellular uptake mechanisms in ASO-based antimalarial strategies.
• Further research is needed to enhance the potency and delivery of these modified oligonucleotides for effective malaria treatment.